Company Name: Blueprint Medicines Corporation     

Blueprint Medicines is a biopharmaceutical company. The company develops kinase inhibitors designed to treat genomically defined cancers and other diseases.

Ticker Symbol: BPMC (NASDAQ)

Company Website: www.blueprintmedicines.com

Social Media:

Blueprint Medicines LinkedIn

Blueprint Medicines Twitter

Headquarters: Cambridge, MA